SEARCH

SEARCH BY CITATION

References

  • AOYAMA, T., INO, Y., OZEKI, M., ODA, M., SATO, T., KOSHIYAMA, Y., SUZUKI, S. & FUJITA, M. (1984). Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments. Jpn. J. Pharmacol., 35, 203227.
  • ARAMOTO, H., SAITO, H., SHIGEMATSU, H. & MUTO, T. (1993). Synthetic protease inhibitors in the treatment of disseminated intravascular coagulation. Nippon Rinsho, 51, 9398.
  • ASSEM, E.S., BRAY, K. & DAWSON, P. (1983). The release of histamine from human basophils by radiological contrast agents. Br. J. Radiol., 56, 647652.
  • BÖHM, S.K., KONG, W., BROMME, D., SMEEKENS, S.P., ANDERSON, D.C., CONNOLLY, A., KAHN, M., NELKEN, N.A., COUGHLIN, S.R., PAYAN, D.G. & BUNNETT, N.W. (1996). Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem. J., 314, 10091016.
  • BOUACHOUR, G., VARACHE, N., SZAPIRO, N., L'HOSTE, P., HARRY, P. & ALQUIER, P. (1991). Noncardiogenic pulmonary edema resulting from intravascular administration of contrast material. Am. J. Roentgenol., 157, 255256.
  • BRASCH, R.C., ROCKOFF, S.D., KUHN, C. & CHRAPLYVY, M. (1970). Contrast media as histamine liberators. II. Histamine release into venous plasma during intravenous urography in man. Invest. Radiol., 5, 510513.
  • COGEN, F.C., NORMAN, M.E., DUNSKY, E., HIRSHFELD, J. & ZWEIMAN, B. (1979). Histamine release and complement changes following injection of contrast media in humans. J. Allergy Clin. Immunol., 64, 299303.
  • CORVERA, C.U., DERY, O., MCCONALOGUE, K., BOHM, S.K., KHITIN, L.M., CAUGHEY, G.H., PAYAN, D.G. & BUNNETT, N.W. (1997). Mast cell tryptase regulates colonic myocytes through proteinase-activated receptor-2. J. Clin. Invest., 100, 13831393.
  • COUGHLIN, S.R. (2000). Thrombin signalling and protease-activated receptors. Nature, 407, 258264.
  • DERY, O., CORVERA, C.U., STEINHOFF, M. & BUNNET, N.W. (1998). Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol., 274, Pt 1, C1429C1452.
  • ERBA, F., FIORUCCI, L., PASCARELLA, S., MENEGATTI, E., ASCENZI, P. & ASCOLI, F. (2001). Selective inhibition of human mast cell tryptase by gabexate mesilate, an antiproteinase drug. Biochem. Pharmacol., 61, 271276.
  • FUJII, S. & HITOMI, Y. (1981). New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin. Biochim. Biophys. Acta., 661, 342345.
  • FURUTA, W., YAMAUCHI, A., DOHGU, S., NAKAGAWA, S., SENDO, T., MAKINO, K., OISHI, R. & KATAOKA, Y. (2002). Contrast media increase vascular endothelial permeability by inhibiting nitric-oxide production. Invest. Radiol., 37, 1319.
  • GENOVESE, A., STELLATO, C., PATELLA, V., LAMPARTER-SCHUMMERT, B., DE CRESCENZO, G., ADT, M. & MARONE, G. (1996). Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue. Int. J. Clin. Lab. Res., 26, 192198.
  • HE, S. & WALLS, A.F. (1997). Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation. Eur. J. Pharmacol., 328, 8997.
  • HOGAN, A.D. & SCHWARTZ, L.B. (1997). Markers of mast cell degranulation. Methods, 13, 4352.
  • ISSEKUTZ, A.C., ROLAND, D.M. & PATRICK, R.A. (1990). The effect of FUT-175 (Nafamstat Mesilate) on C3a, C4a and C5a generation in vitro and inflammatory reactions in vivo. Int. J. Immunopharmacol., 12, 19.
  • ITOH, Y., OISHI, R., ADACHI, N. & SAEKI, K. (1992). A highly sensitive assay for histamine using ion-pair HPLC coupled with postcolumn fluorescent derivatization. J. Neurochem., 58, 884889.
  • JACOBI, H.H., SKOV, P.S., KAMPEN, G.T., POULSEN, L.K., REIMERT, C.M., BINDSLEV-JENSEN, C., PRAETORIUS, C., MALLING, H.J. & MYGIND, N. (1998). Histamine and tryptase in nasal lavage fluid following challenge with methacholine and allergen. Clin. Exp. Allergy, 28, 8391.
  • KAWABATA, A., KURODA, R., MINAMI, T., KATAOKA, K. & TANEDA, M. (1998). Increased vascular permeability by a specific agonist of protease-activated receptor-2 in rat hindpaw. Br. J. Pharmacol., 125, 419422.
  • LAMPUGNANI, M.G., CORADA, M., CAVEDA, L., BREVIARIO, F., AYALON, O., GEIGER, B. & DEJANA, E.R. (1995). The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, β-catenin, and α-catenin with vascular endothelial cadherin (VE-cadherin). J. Cell Biol., 129, 203217.
  • LAROCHE, D., AIMONE-GASTIN, I., DUBOIS, F., HUET, H., GERARD, P., VERGNAUD, M.C., MOUTON-FAIVRE, C., GUEANT, J.L., LAXENAIRE, M.C. & BRICARD, H. (1998). Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology, 209, 183190.
  • LIEBERMAN, P. (1990). The use of antihistamines in the prevention and treatment of anaphylaxis and anaphylactoid reactions. J. Allergy Clin. Immunol., 86, 684686.
  • MENEGATTI, E., BOLOGNESI, M., SCALIA, S., BORTOLOTTI, F., GUARNERI, M. & ASCENZI, P. (1986). Gabexate mesylate inhibition of serine proteases: thermodynamic and computer-graphics analysis. J. Pharm. Sci., 75, 11711174.
  • MITA, H., TADAKORO, K. & AKIYAMA, K. (1998). Detection of IgE antibody to a radiocontrast medium. Allergy, 53, 11331140.
  • MOLINO, M., BARNATHAN, E.S., NUMEROF, R., CLARK, J., DREYER, M., CUMASHI, A., HOXIE, J.A., SCHECHTER, J.A., WOOLKALIS, M. & BRASS, L.F. (1997). Interaction of mast cell tryptase with thrombin receptors and PAR-2. J. Biol. Chem., 272, 40434049.
  • MOLLA, A., YAMAMOTO, T. & MAEDA, H. (1988). Characterization of 73 kDa thiol protease from Serratia marcescens and its effect on plasma proteins. J. Biochem. (Tokyo), 104, 616621.
  • MURAMATU, M., ITOH, T., TAKEI, M. & ENDO, K. (1988). Tryptase in rat mast cells: properties and inhibition by various inhibitors in comparison with chymase. Biol. Chem. Hoppe. Seyler., 369, 617625.
  • NYSTEDT, S., EMILSSON, K., WAHLESTEDT, C. & SUNDELIN, J. (1994). Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci. U.S.A., 91, 92089212.
  • RABIET, M.J., PLANTIER, J.L., RIVAL, Y., GENOUX, Y., LAMPUGNANI, M.G. & DEJANA, E. (1996). Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler. Thromb. Vasc. Biol., 16, 488496.
  • RICCIARDOLO, F.L., STEINHOFF, M., AMADESI, S., GUERRINI, R., TOGNETTO, M., TREVISANI, M., CREMINON, C., BERTRAND, C., BUNNETT, N.W., FABBRI, L.M., SALVADORI, S. & GEPPETTI, P. (2000). Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways. Am. J. Respir. Crit. Care Med., 161, 16721680.
  • RAMJEE, M.K., HENDERSON, I.M., MCLOUGHLIN, S.B. & PADOVA, A. (2000). The kinetic and structural characterization of the reaction of nafamostat with bovine pancreatic trypsin. Thromb. Res., 98, 559569.
  • ROBERTSON, P.W., FREWIN, D.B., ROBERTSON, A.R., MAHAR, L.J. & JONSSON, J.R. (1985). Plasma histamine levels following administration of radiographic contrast media. Br. J. Radiol., 58, 10471051.
  • SAIFEDDINE, M., AL-ANI, B., CHENG, C.H., WANG, L. & HOLLENBERG, M.D. (1996). Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br. J. Pharmacol., 118, 521530.
  • SCHWARTZ, L.B. (1990). Tryptase, a mediator of human mast cells. J. Allergy Clin. Immunol., 86, 594598.
  • SCHWARTZ, L.B., IRANI, A.A., ROLLER, K., CASTELLS, M.C. & SCHECHTER, N.M. (1987). Quantitation of histamine, tryptase and chymase in dispersed human T and TC mast cells. J. Immunol., 138, 26112615.
  • SENDO, T., KATAOKA, Y., TAKEDA, Y., FURUTA, W. & OISHI, R. (2000). Nitric oxide protects against contrast media-increased pulmonary vascular permeability in rats. Invest. Radiol., 35, 472478.
  • STELLATO, C., DE CRESCENZO, G., PATELLA, V., MASTRONARDI, P., MAZZARELLA, B. & MARONE, G. (1996). Human basophil/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator release. J. Allergy Clin. Immunol., 97, 838850.
  • SUEYASU, M., KOMASU, C., HARA, T., FUTAGAMI, K., KATAOKA, Y. & OISHI, R. (1997). Enhancement by morphine of radiographic contrast media-induced histamine release in rat peritoneal mast cells. Jpn. J. Pharmacol., 74, 217220.
  • SWYSTUN, V.A., GORDON, J.R., DAVIS, E.B., ZHANG, X. & COCKCROFT, D.W. (2000). Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J. Allergy Clin. Immunol., 106, 5764.
  • VERGNOLLE, N., HOLLENBERG, M.D., SHARKEY, K.A. & WALLACE, J.L. (1999). Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR-2)-activating peptides in the rat paw. Br. J. Pharmacol., 127, 10831090.
  • VERGNOLLE, N., WALLACE, J.L., BUNNETT, N.W. & HOLLENBERG, M.D. (2001). Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol. Sci., 22, 146152.
  • WENZEL, S.E., FOWLER, A.A. & SCHWARTZ, L.B. (1988). Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with or without asthma. Am. Rev. Respir. Dis., 137, 10021008.